SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $473,000 | +19.4% | 27,882 | 0.0% | 0.01% | +25.0% |
Q2 2018 | $396,000 | -25.3% | 27,882 | -0.1% | 0.00% | -42.9% |
Q1 2018 | $530,000 | +15.5% | 27,916 | -0.3% | 0.01% | +16.7% |
Q4 2017 | $459,000 | -1.1% | 27,992 | -9.5% | 0.01% | -14.3% |
Q3 2017 | $464,000 | -9.7% | 30,923 | -47.0% | 0.01% | -12.5% |
Q2 2017 | $514,000 | +233.8% | 58,378 | +97.4% | 0.01% | +166.7% |
Q1 2017 | $154,000 | – | 29,576 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rokos Capital Management LLP | 6,474,348 | $11,394,852 | 0.84% |
WASATCH ADVISORS LP | 13,642,417 | $24,010,654 | 0.15% |
Avidity Partners Management LP | 2,470,000 | $4,347,200 | 0.14% |
Acrisure Capital Management, LLC | 75,832 | $133,464 | 0.14% |
Golden State Equity Partners | 135,765 | $238,946 | 0.13% |
Long Focus Capital Management, LLC | 1,072,000 | $1,886,720 | 0.11% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $78,008 | 0.10% |
CAXTON ASSOCIATES LP | 288,218 | $507,264 | 0.08% |
XTX Topco Ltd | 206,334 | $363,148 | 0.08% |
Rhenman & Partners Asset Management AB | 314,157 | $534,067 | 0.06% |